Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13G Filing: Taylor Asset Management Trims Stake in Can Fite Biopharma Ltd. (CANF)

We are seeing a lot of 13G filing activity at the moment and one of the more interesting filings is this one submitted to the SEC by Taylor Asset Management. This filing details the investor’s latest position in Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF), including the amount of shares owned at 553,100, down from 568,000 at the end of December. While the drop in share ownership is slight, the fund’s percentage of ownership has nonetheless fallen to 4.00% from 5.33%, given that there are now more shares in circulation.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Taylor Asset Management Inc 553,100 0 553,100 0 553,100 4.00%

Page 1 of 6 SEC Filing



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G/A
Under the Securities Exchange Act of 1932.
(Amendment No.  1)*
 
Can-Fite Biopharma Ltd.
(Name of Issuer)
 
Sponsored ADR
(Title of Class of Securities)
 
13471N102 
 
 
(CUSIP Number)
 
 
February 12, 2016
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
x Rule 13d-1(b)
¨ Rule 13d-1(c)
¨ Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


Loading...